PB8 Stock Overview Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Phibro Animal Health Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Phibro Animal Health Historical stock prices Current Share Price US$20.80 52 Week High US$23.80 52 Week Low US$9.65 Beta 0.52 1 Month Change 4.00% 3 Month Change -0.95% 1 Year Change 111.17% 3 Year Change 25.30% 5 Year Change -16.13% Change since IPO -20.58%
Recent News & Updates
Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors Jan 24
Phibro Animal Health Corporation to Report Q2, 2025 Results on Feb 05, 2025 Jan 23
Investor sentiment improves as stock rises 18% Nov 13
First quarter dividend of US$0.12 announced Nov 10
New minor risk - Earnings quality Nov 08
First quarter 2025 earnings released: EPS: US$0.17 (vs US$0.20 loss in 1Q 2024) Nov 07 See more updates
Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors Jan 24
Phibro Animal Health Corporation to Report Q2, 2025 Results on Feb 05, 2025 Jan 23
Investor sentiment improves as stock rises 18% Nov 13
First quarter dividend of US$0.12 announced Nov 10
New minor risk - Earnings quality Nov 08
First quarter 2025 earnings released: EPS: US$0.17 (vs US$0.20 loss in 1Q 2024) Nov 07
Phibro Animal Health Corporation Updates Standalone Financial Guidance for Fiscal Year Ending June 30, 2025 and Provides Preliminary Financial Guidance for the Eight Months in Fiscal Year 2025 Nov 07
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on December 18, 2024 Nov 06
Phibro Animal Health Corporation to Report Q1, 2025 Results on Nov 06, 2024 Oct 24
Phibro Animal Health Corporation, Annual General Meeting, Nov 05, 2024 Sep 23
New minor risk - Earnings quality Aug 30
Full year 2024 earnings released: EPS: US$0.06 (vs US$0.81 in FY 2023) Aug 29
Phibro Animal Health Corporation Provides Earning Guidance for the Year Ending June 30, 2025 Aug 29
Investor sentiment improves as stock rises 16% Aug 28
Upcoming dividend of US$0.12 per share Aug 28
Phibro Animal Health Corporation to Report Q4, 2024 Results on Aug 28, 2024 Aug 15
Third quarter dividend of US$0.12 announced Aug 05
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on September 25, 2024 Jul 31
New major risk - Share price stability Jul 19
Investor sentiment improves as stock rises 16% Jul 18
Upcoming dividend of US$0.12 per share May 29
Third quarter dividend of US$0.12 announced May 13
Phibro Animal Health Corporation Updates Earnings Guidance for the Year 2024 May 10
Third quarter 2024 earnings released: EPS: US$0.21 (vs US$0.25 in 3Q 2023) May 09
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on June 26, 2024 May 08
Investor sentiment improves as stock rises 32% May 03 Phibro Animal Health Corporation (NasdaqGM:PAHC) entered into a definitive agreement to acquire Medicated feed additive product portfolio, certain water soluble products and related assets of Zoetis Inc. (NYSE:ZTS) for approximately $350 million. Apr 30
Phibro Animal Health Corporation to Report Q3, 2024 Results on May 08, 2024 Apr 20
Upcoming dividend of US$0.12 per share Feb 27
Second quarter dividend of US$0.12 announced Feb 12
Second quarter 2024 earnings released: EPS: US$0.031 (vs US$0.18 in 2Q 2023) Feb 08
Phibro Animal Health Corporation Reaffirms Earnings Guidance for the Fiscal Year 2024 Feb 08
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on March 27, 2024 Feb 07
Phibro Animal Health Corporation Announces Chief Financial Officer Changes, Effective February 9, 2024 Feb 06
Phibro Animal Health Corporation to Report Q2, 2024 Results on Feb 07, 2024 Jan 17
Investor sentiment improves as stock rises 19% Dec 07
Upcoming dividend of US$0.12 per share at 4.4% yield Nov 21
Investor sentiment deteriorates as stock falls 19% Nov 15
New minor risk - Share price stability Nov 11
Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024 Nov 10
First quarter 2024 earnings released: US$0.20 loss per share (vs US$0.095 profit in 1Q 2023) Nov 09
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on December 20, 2023 Nov 07
Phibro Animal Health Corporation to Report Q1, 2024 Results on Nov 08, 2023 Oct 18
Phibro Animal Health Corporation, Annual General Meeting, Nov 06, 2023 Sep 16
Phibro Animal Health Corporation Announces Chief Financial Officer Changes Sep 07
Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024 Sep 01
Full year 2023 earnings released: EPS: US$0.81 (vs US$1.21 in FY 2022) Aug 31
Upcoming dividend of US$0.12 per share at 3.2% yield Aug 29
Phibro Animal Health Corporation to Report Q4, 2023 Results on Aug 30, 2023 Aug 01
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on September 27, 2023 Jul 26
Upcoming dividend of US$0.12 per share at 3.6% yield May 30
Third quarter 2023 earnings released: EPS: US$0.25 (vs US$0.44 in 3Q 2022) May 05
Phibro Animal Health Corporation Reiterates Earnings Guidance for the Year Ending June 30, 2023 May 05
Upcoming dividend of US$0.12 per share at 2.9% yield Feb 21
Second quarter 2023 earnings released: EPS: US$0.18 (vs US$0.43 in 2Q 2022) Feb 10
Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023 Feb 09 Phibro Animal Health Corporation Appoints Alejandro Bernal to Its Board of Directors
Phibro Animal Health Corporation to Report Q2, 2023 Results on Feb 08, 2023 Jan 10
Upcoming dividend of US$0.12 per share Nov 22
Insufficient new directors Nov 16
First quarter 2023 earnings released: EPS: US$0.095 (vs US$0.16 in 1Q 2022) Nov 11
Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023 Nov 10
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on December 21, 2022 Nov 08
Phibro Animal Health Corporation to Report Q1, 2023 Results on Nov 09, 2022 Oct 04
Phibro Animal Health Corporation, Annual General Meeting, Nov 07, 2022 Sep 17
Upcoming dividend of US$0.12 per share Aug 30
Full year 2022 earnings released: EPS: US$1.21 (vs US$1.34 in FY 2021) Aug 26
Phibro Animal Health Corporation Provides Financial Guidance for the Year Ending June 30, 2023 Aug 25
Phibro Animal Health Corporation to Report Q4, 2022 Results on Aug 24, 2022 Jul 28
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on September 28, 2022 Jul 26
Upcoming dividend of US$0.12 per share May 24
Third quarter 2022 earnings released: EPS: US$0.44 (vs US$0.30 in 3Q 2021) May 06
Phibro Animal Health Corporation Raises Sales Guidance for the Fiscal Year Ending June 30, 2022 May 05
Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on June 22, 2022 May 03
Insufficient new directors Apr 27
Phibro Animal Health Corporation to Report Q3, 2022 Results on May 04, 2022 Apr 05
Upcoming dividend of US$0.12 per share Feb 22
Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Feb 10
Phibro Animal Health Corporation Revises Sales Guidance for the Year Ending June 30, 2022 Feb 10
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on March 23, 2022 Feb 08
Upcoming dividend of US$0.12 per share Nov 16
First quarter 2022 earnings released: EPS US$0.16 (vs US$0.30 in 1Q 2021) Nov 03
Independent Non-Executive Director recently bought €100k worth of stock Sep 02
Insufficient new directors Sep 02
Full year 2021 earnings released: EPS US$1.34 (vs US$0.83 in FY 2020) Aug 26
Phibro Animal Health Corporation Provides Earnings Guidance for the Year Ending June 30, 2022 Aug 26
Upcoming dividend of US$0.12 per share Aug 24
Investor sentiment deteriorated over the past week Jul 10 Phibro Animal Health Corporation(NasdaqGM:PAHC) dropped from Russell 3000E Value Index
Upcoming dividend of US$0.12 per share May 25
Third quarter 2021 earnings released: EPS US$0.30 (vs US$0.33 in 3Q 2020) May 08 Shareholder Returns PB8 DE Pharmaceuticals DE Market 7D 0% 2.6% 1.9% 1Y 111.2% -9.1% 14.1%
See full shareholder returns
Return vs Market: PB8 exceeded the German Market which returned 14.1% over the past year.
Price Volatility Is PB8's price volatile compared to industry and market? PB8 volatility PB8 Average Weekly Movement 5.4% Pharmaceuticals Industry Average Movement 5.4% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.0% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: PB8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PB8's weekly volatility (5%) has been stable over the past year.
About the Company Founded Employees CEO Website 1946 1,940 Jack Bendheim www.pahc.com
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Show more Phibro Animal Health Corporation Fundamentals Summary How do Phibro Animal Health's earnings and revenue compare to its market cap? PB8 fundamental statistics Market cap €852.43m Earnings (TTM ) €16.73m Revenue (TTM ) €1.01b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) PB8 income statement (TTM ) Revenue US$1.05b Cost of Revenue US$717.38m Gross Profit US$329.38m Other Expenses US$311.98m Earnings US$17.41m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
Earnings per share (EPS) 0.43 Gross Margin 31.47% Net Profit Margin 1.66% Debt/Equity Ratio 184.7%
How did PB8 perform over the long term?
See historical performance and comparison Dividends
2.2% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/30 03:18 End of Day Share Price 2025/01/30 00:00 Earnings 2024/09/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Phibro Animal Health Corporation is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Balaji Prasad Barclays Matthew Korn Barclays Douglas Tsao Barclays
Show 12 more analysts 
